Skip to content
CureGene
-
CureGene administers first patient in pivotal US trial of antiplatelet Evategrel
Researchers will assess the drug’s efficacy and safety in patients with acute coronary syndrome (ACS), recent myocardial infarction, ischemic stroke, and peripheral arterial disease.